• All
  • Primary Antibodies
  • Conjugated Antibodies for IF
  • Conjugated Antibodies for FC
  • Secondary Antibodies
  • Antibody Labeling KitsNew
  • ELISA Kits
  • IHC Kits
  • Magnetic Cell Separation Kits
  • Cytokines & Growth Factors
  • Neutralizing/activating Antibodies
  • Nanobody-based Reagents
  • Accessory Products and Kits
  • Fusion Proteins
×
×
Host
0
Species Reactivity
0
Species Reactivity
0
Conjugate
0
Conjugate
0
Compatible Species
0
Conjugate
0

SMYD4 Monoklonaler Antikörper

SMYD4 Monoklonal Antikörper für WB, Indirect ELISA

Wirt / Isotyp

Maus / IgG1

Getestete Reaktivität

human

Anwendung

WB, Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

2F4B7

Kat-Nr. : 66874-1-PBS

Synonyme

KIAA1936, SMYD4, ZMYND21

Filter:
  • Western Blot (WB) analysis of MCF-7 cells using SMYD4 Monoclonal antibody (66874-1-Ig)

    WB analysis of MCF-7 using 66874-1-Ig (same clone as 66874-1-PBS)

    MCF-7 cells were subjected to SDS PAGE followed by western blot with 66874-1-Ig (SMYD4 antibody) at dilution of 1:3000 incubated at room temperature for 1.5 hours. This data was developed using the same antibody clone with 66874-1-PBS in a different storage buffer formulation.

Geprüfte Anwendungen

Produktinformation

66874-1-PBS bindet in WB, Indirect ELISA SMYD4 und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Maus / IgG1
Klonalität Monoklonal
Typ Antikörper
Immunogen SMYD4 fusion protein Ag11552
Vollständiger Name SET and MYND domain containing 4
Berechnetes Molekulargewicht 804 aa, 89 kDa
Beobachtetes Molekulargewicht 85-89 kDa
GenBank-ZugangsnummerBC035077
Gene symbol SMYD4
Gene ID (NCBI) 114826
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-G-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

SMYD4, also named as SET and MYND domain-containing protein 4, is a 804 amino acid protein, which contains 1 MYND-type zinc finger and 1 SET domain. SMYD4 belongs to the class V-like SAM-binding methyltransferase superfamily. SMYD4, as a potential tumor suppressor, plays a critical role in breast carcinogenesis at least partly through inhibiting the expression of Pdgfr-alpha, and could be a novel target for improving treatment of breast cancer. SMYD4 is a muscle-specific transcriptional modulator involved in development.